EC Number |
Disease |
PubMed ID |
Title of Publication |
Category |
Confidence Level |
---|
2.1.1.57 | Acquired Immunodeficiency Syndrome |
33159807 |
1H, 13C, and 15N backbone chemical shift assignments of coronavirus-2 non-structural protein Nsp10. |
unassigned |
0 |
2.1.1.57 | Arteritis |
26041874 |
Arterivirus nsp12 versus the coronavirus nsp16 2'-O-methyltransferase: comparison of the C-terminal cleavage products of two nidovirus pp1ab polyproteins. |
ongoing research unassigned |
1 0 |
2.1.1.57 | Asthma |
26734457 |
CMTR1 is associated with increased asthma exacerbations in patients taking inhaled corticosteroids. |
causal interaction therapeutic application unassigned |
4 4 0 |
2.1.1.57 | Carcinoma, Ehrlich Tumor |
3415705 |
Specificity of a nucleolar 2'-O-methyltransferase for RNA substrates. |
diagnostic usage ongoing research unassigned |
1 4 0 |
2.1.1.57 | Carcinoma, Ehrlich Tumor |
3593683 |
Isolation and characterization of a nucleolar 2'-O-methyltransferase from Ehrlich ascites tumor cells. |
diagnostic usage ongoing research unassigned |
3 4 0 |
2.1.1.57 | Coronavirus Infections |
28031370 |
Binding of the Methyl Donor |
unassigned |
0 |
2.1.1.57 | Coronavirus Infections |
29152578 |
Middle East Respiratory Syndrome Coronavirus Nonstructural Protein 16 Is Necessary for Interferon Resistance and Viral Pathogenesis. |
causal interaction therapeutic application unassigned |
3 1 0 |
2.1.1.57 | COVID-19 |
32397643 |
Potential Drugs Targeting Early Innate Immune Evasion of SARS-Coronavirus 2 via 2'-O-Methylation of Viral RNA. |
unassigned |
0 |
2.1.1.57 | COVID-19 |
32741322 |
Identification of promising drug candidates against NSP16 of SARS-CoV-2 through computational drug repurposing study. |
therapeutic application unassigned |
4 0 |
2.1.1.57 | COVID-19 |
33020707 |
Structural insight into the recognition of S-adenosyl-L-homocysteine and sinefungin in SARS-CoV-2 Nsp16/Nsp10 RNA cap 2'-O-Methyltransferase. |
therapeutic application unassigned |
3 0 |